idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
22.02.2022 11:00

Improving the prediction of pregnancy complications using artificial intelligence

Dr. Stefanie Seltmann Presse- und Öffentlichkeitsarbeit
Berlin Institute of Health in der Charité (BIH)

    One in ten pregnant women experience signs of preeclampsia – elevated blood pressure and increased protein in the urine – at some point in their pregnancy. Only a few of these women actually go on to have serious complications. But since these can lead to the death of the mother and baby, the pregnant women are often admitted to the hospital just to be safe, though in most cases this turns out in retrospect to have been unnecessary. Scientists at Charité – Universitätsmedizin Berlin have collected data from 1,647 preeclampsia patients and used machine learning methods to create a model that can better predict the probability of serious complications.

    Preeclampsia, formerly known as toxemia of pregnancy, has a variety of signs and symptoms: The blood pressure rises suddenly and quickly; excessive protein is found in the urine; fluid accumulates in the arms or legs, a condition known as edema; those affected experience dizziness, headaches, nausea or upper abdominal pain. “About 10 to 15 percent of all pregnant women have a clinical suspicion of preeclampsia at least once during their pregnancy,” reports Professor Stefan Verlohren, senior physician in the Department of Obstetrics at Campus Charité Mitte. “Yet only two to five percent actually develop the disease, and serious complications occur in only a small proportion of these women.”

    “More accurate predictions simply cannot be achieved through blood pressure and urine protein measurement alone. And although we’ve recently introduced new biomarkers like sFlt-1 and PIGF, we wanted to explore the hypothesis of using machine learning algorithms to jointly analyze multiple test results in order to better predict who is at risk and who is not.”

    1,647 patient data sets were evaluated

    First, the scientists led by Verlohren compiled a database of real treatment data from a total of 1,647 high-risk preeclampsia patients who presented at Charité’s Department of Obstetrics between 2010 and 2019. With the help of these data sets, the team used machine learning methods or artificial intelligence (AI) to calculate how likely it is that complications would occur. They included a total of 114 different features in the evaluation.

    “After training the algorithms with the clinical data sets, we compared the prediction accuracy of our AI model with the traditional prediction method based on clinical parameters,” Leon Schmidt, who is conducting his doctoral thesis in Verlohrens group, reports. “Our algorithms were clearly superior to the traditional predictions based on blood pressure, proteinuria and the sFlt-1/PlGF ratio. Of particular note was that the positive predictive value – i.e., that a complication will actually occur – was double as accurate.”

    AI cannot replace doctors – but it can lend a helping hand

    The Digital Health Accelerator Program of the Berlin Institute of Health at Charité (BIH) is supporting further product development so that a solution based on the newly created algorithm can be rapidly translated into broad clinical practice, thus making it widely available to patients and doctors in the future. However, prospective studies must first confirm the validity of the algorithm. “AI of course cannot replace physicians,” Verlohren, a physician himself, is convinced. “But when it comes to considering how preeclampsia treatment should proceed, AI certainly provides a better basis for making decisions. This could prevent potentially life-threatening complications for both mother and child.”


    Wissenschaftliche Ansprechpartner:

    Dr. Stefan Verlohren


    Originalpublikation:

    Originalveröffentlichung: Am J Obstet Gynecol. 2022 Jan 31:S0002-9378(22)00050-3.
    doi: 10.1016/j.ajog.2022.01.026


    Bilder

    Merkmale dieser Pressemitteilung:
    Journalisten, jedermann
    Biologie, Informationstechnik, Medizin
    überregional
    Forschungs- / Wissenstransfer, Wissenschaftliche Publikationen
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).